Effects of Cognitive Stimulation in Older People With Mild Cognitive Impairment

May 20, 2022 updated by: Agustín Aibar Almazán, University of Jaén

Effectiveness of a Cognitive Stimulation Program on Anxiety, Depression and Quality of Life in People Older Than 70 Years With Mild Cognitive Impairment.

Mild cognitive impairment is becoming one of the most common cynical manifestations that affect older people. That is why there is a need to investigate non-pharmacological interventions that help to improve or maintain this problem.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Each week for 12 weeks, GE participants will attend three 60-minute sessions of cognitive exercises. Each session is divided into 10 minutes of memory practice, which includes short-term and long-term memory; 10 minutes of language skills, including vocabulary, comprehension, reading and writing exercises; 10 minutes of calculation, in which arithmetic, similar and different operations are carried out; 10 minutes of praxis and gnosis where drawing and recognition and auditory, tactile, spatial, visual attention were promoted; 10 minutes of orientation where knowledge of space, person and place is developed; and 10 minutes of executive functions in which exercises of organization, planning and problem solving are worked.

Study Type

Interventional

Enrollment (Actual)

85

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Jaén, Spain, 23330
        • U.E.D. Virgen de la Capilla

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • With or without dependency to move.
  • People who show mild cognitive impairment.
  • That they were able to carry out the different selected questionnaires.

Exclusion Criteria:

  • People with visual deficit.
  • People already enrolled in a cognitive program.
  • Score between 24 and 10 in the Mini Cognitive Exam (MEC).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
This group does not receive any treatment.
Experimental: Cognitive Stimulation Group
This group receives physical training based on exercises for cognitive stimulation.
Each week for 12 weeks, GE participants attend three 60-minute sessions of cognitive exercises.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
MMSE (mini-mental state examination)
Time Frame: Baseline-8 weeks
A tool that can be used to systematically and thoroughly assess mental status.
Baseline-8 weeks
Yesavage Geriatric Depression Scale Adjetivo 1 relating to old people, especially with regard to their healthcare. a geriatric hospital Sustantivo 1 an old person, especially one receiving special care. a rest home for geriatrics.
Time Frame: Baseline-8 weeks
Hetero-administered questionnaire used to detect depression in people over 65 years of age.
Baseline-8 weeks
Hamilton Scale for Anxiety.
Time Frame: Baseline-8 weeks
Hetero-administered scale used for the detection of anxiety, exploring the interruption of the emotional continum and subjective feelings of tension, restlessness or nervousness.
Baseline-8 weeks
SF-36 (The Short Form-36 Health Survey)
Time Frame: Baseline-8 weeks
Used extensively for assessing health-related quality of life.
Baseline-8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 11, 2021

Primary Completion (Actual)

April 5, 2021

Study Completion (Actual)

April 12, 2021

Study Registration Dates

First Submitted

November 15, 2020

First Submitted That Met QC Criteria

December 4, 2020

First Posted (Actual)

December 10, 2020

Study Record Updates

Last Update Posted (Actual)

May 26, 2022

Last Update Submitted That Met QC Criteria

May 20, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • University of Jaén_2020

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Cognitive Impairment

Clinical Trials on Cognitive stimulation group

Subscribe